JDD

Glycopyrronium Tosylate Cloth for Hyperhidrosis Therapeutic Cheat Sheet
Qbrexza Therapeutic Cheat SheetHyperhidrosis affects approximately 4.8% of the U.S. population1 and causes patients significant psychosocial distress. Patients are looking to maximize non-invasive treatment options while avoiding systemic side effects. We continue our series, Therapeutic Cheat Sheet, with a closer look at glycopyrronium tosylate cloths. [caption id="attachment_11862" align="alignleft" width="1934"] Click ima …
Qbrexza Therapeutic Cheat Sheet
JDD November Issue Highlights: Lasers, Light Sources, and Devices
JDD November 2020 Issue HighlightsThe November issue of the Journal of Drugs in Dermatology focuses on the topics of Lasers, Light Sources, and Devices, featuring an outstanding line-up of original articles. Straight from the JDD Editor’s desk, we share this month’s issue highlights The Guest Editorial by Dr. Macrene Alexiades focuses on the growing body of objective quantifiable data demonstrating time-sensitive improvemen …
JDD November 2020 Issue Highlights
JDD September Issue Highlights
Below are the issue highlights for the September issue of the JDD. Randomized, Double-Blinded, Split-Face Study Comparing the Efficacy and Tolerability of Two Topical Products in Melasma compares a HQ-free, retinol-free cosmetic topical brightener and HQ 4% in patients with skin types III-VI. Complication of Soft Tissue Fillers: Prevention and Management Review highlights the various advers …
Widespread Skin Necrosis Secondary to Gemcitabine Therapy
Skin Necrosis INTRODUCTION Cutaneous side effects are relatively common in chemotherapy but vary in frequency and severity depending on the medication, dose, duration, pharmacokinetics, and pharmacodynamics. Gemcitabine, a pyrimidine nucleoside analogue, is a common oncologic agent used in the treatment of a variety of malignancies such as cancers of the head and neck, lung cancer, breast cancer, pancreatic …
Skin Necrosis
JDD August Issue Highlights
Here are the issue highlights and Editor Picks for the August issue of JDD: Clearance of psoriasis leads to greater uptake of cosmetic procedures in Increased Trend of Cosmetic Procedures in Patients With Psoriasis Who Attain 75% or Greater Improvement. The Effect of Tildrakizumab on Cardiometabolic Two Phase 3 Trials (reSURFACE 1 and reSURFACE 2) examines the impact of IL-23 inhibition on c …